Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer

Evaluating Prostate Cancer with Multiparametric MRI

Recruiting
18 years - 100 years
Male
1 Location

Brief description of study.

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer.

Detailed description of study

Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Prostate Carcinoma,Prostate Cancer
  • Age: 18 years - 100 years
  • Gender: Male

Inclusion Criteria

Recently diagnosed with prostate cancer for whom definitive surgical treatment is indicated

Exclusion Criteria

Not suitable to undergo MRI or receive gadolinium-based contrast agent (severe, untreatable claustrophobia; MRI-incompatible metallic objects or implanted medical devices; renal failure; weight greater than allowable by scanner per institutional standard practice)

Prior surgical and/or non-surgical treatment for prostate cancer

Prior hip replacement or other major pelvic surgery

Updated on 19 Feb 2024. Study ID: 1902624997 (RADY-ECOG-ACRIN-EA8171)

This study investigates how multiparametric magnetic resonance imaging (MRI) can be used to evaluate the stage of prostate cancer and assist in planning treatment. Prostate cancer is a disease where cells in the prostate grow uncontrollably. Multiparametric MRI is a type of scan that uses different methods to create detailed images of the prostate, which may help in identifying aggressive forms of cancer.

Participants in the study will undergo a multiparametric MRI scan. This procedure involves using magnetic fields and radio waves to take pictures of the prostate. These images help doctors understand the cancer better and plan the most appropriate treatment.

  • Who can participate: Men who have been recently diagnosed with prostate cancer and need surgical treatment may be eligible to participate. Individuals must be able to undergo an MRI and receive gadolinium-based contrast agent.
  • Study details: Participants will undergo a scan to evaluate their prostate cancer.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here